Genetic polymorphisms in aquaporin 1 as risk factors for malignant mesothelioma and biomarkers of response to cisplatin treatment

Genetic polymorphisms in aquaporin 1 as risk factors for malignant mesothelioma and biomarkers of response to cisplatin treatment

Malignant mesothelioma (MM) is an asbestos related aggressive tumor with poor prognosis. The aim of this study was to investigate if aquaporin 1 (AQP1) genetic polymorphisms influence the risk of MM and the response to cisplatin based MM treatment.

Bibliographic Details
Main Authors: Senk Barbara, Goricar Katja, Kovac Viljem, Dolzan Vita, Franko Alenka
Format: Article
Language:English
Published: Sciendo 2019-03-01
Series:Radiology and Oncology
Subjects:
malignant mesothelioma
aqp1
polymorphism
cisplatin
Online Access:https://doi.org/10.2478/raon-2019-0009

Similar Items

Similar Items